chronic myelogenous leukemia

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Fayetteville, Arkansas
    • +22 more
    Jun 29, 2021

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Tampa, Florida
    • +11 more
    Sep 3, 2020

    Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

    Completed
    • Acute Myeloid Leukemia
    • +10 more
    • Chicago, Illinois
      University of Illinois at Chicago Medical Center
    Oct 9, 2018

    Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (Fludarabine, Melphalan, Stem

    Completed
    • Acute Myelogenous Leukemia
    • +8 more
    • Chicago, Illinois
      The University of Chicago
    Oct 7, 2016

    Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))

    Completed
    • Chronic Myelogenous Leukemia
    • imatinib mesilate
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Aug 7, 2013

    Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • VCL-CB01
    • Phosphate-buffered Saline (PBS)
    • Tucson, Arizona
    • +21 more
    Jul 31, 2013

    Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

    Completed
    • Chronic Myelogenous Leukemia
    • Birmingham, Alabama
    • +69 more
    Apr 13, 2011